AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT03139461 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: PT-REFER Capacity-building Toolkit
Description: 1. Written guidelines for building partnerships with physical therapists. Information includes information on who to contact, how to contact them, and how to present information about the program (e.g., evidence base, program structure)~2. Support from Change Agent~3. Technical Assistance Calls
Study NCT04663074 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: IVUS control
Description: Intravascular Control of the bridging stentgrafts during branched EVAR
Study NCT01354431 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: nivolumab
Description: Solution, Intravenous (IV), 0.3 mg/kg, every 3 weeks (Q 3 weeks), Until Progressive disease (PD), toxicity or discontinue for other reasons
Study NCT01354431 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: nivolumab
Description: Solution, Intravenous (IV), 2.0 mg/kg, every 3 weeks (Q 3 weeks), Until Progressive disease (PD), toxicity or discontinue for other reasons
Study NCT01354431 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: nivolumab
Description: Solution, Intravenous (IV), 10.0 mg/kg, every 3 weeks (Q 3 weeks), Until Progressive disease (PD), toxicity or discontinue for other reasons
Study NCT01595165 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ultrasound guided subcostal TAP block
Description: Under ultrasound guidance0.375% ropivacaine 10 ml will be injected between rectus abdominis and transverse abdominis and same study solution will be injected at subcostal transversus abdominis plane. This block will be done bilaterally.
Study NCT01595165 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Ultrasound guided subcostal TAP block
Description: Under ultrasound guidance saline 10 ml will be injected between rectus abdominis and transverse abdominis and same study solution will be injected at subcostal transversus abdominis plane. This block will be done bilaterally.
Study NCT02790333 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: traditional reloads
Description: Blue cartridge with3.0mm height staple was used for pancreatic stump
Study NCT02790333 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Tri-Staple reloads
Description: Purple cartridge with2.0-2.5-3.0mm varied-height staples was used for pancreatic stump
Study NCT03532984 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Beam test to predict falls
Description: Dynamic balance will be determined in all participants during beam walking. The beams are 4m long, 2cm high, and 4, 8, and 12cm wide. After a practice trial, participants will perform three trials on each width with and without a calculation task. Trials will be block-randomized based on beam width then on task. Instructions: 'Traverse the entire length of the beam safely at your preferred speed without stepping off, facing forward, with your arms folded in front of your chest. Trials end when you step off, walk sideways, or unfold the arms.' Outcomes are the sum of length traversed, average velocity, number of steps, and average step length determined from video recordings made at 90° relative to the walking direction with full beam length in view using off-the-shelf video cameras.
Study NCT02595047 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: tissue/ organ prefabrication
Description: tissue/ organ is prefabricated in vivo independent of exogenous factors for replacement/ reconstruction purposes
Study NCT04065191 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High-intensity interval training
Description: Heart rate based high-intensity interval training
Study NCT03101059 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Non invasive ventilation - Continuous Positive Airway Pressure
Description: To identify, through bronchoscopy, the prevalence of collapse and whether it is possible to counteract an optimum pressure generated by NIV with CPAP that reduces tracheal and bronchial collapse in patients with SMK; To study the frequency of OSAS in patients with MKS ; Record reversal of collapse with CPAP using chest tomography; To identify the impact of CPAP on the distribution of pulmonary ventilation through the analysis of electrical impedance tomography.
Study NCT02294318 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: HealthCall+Motivational Interviewing
Description: HealthCall is a technology-based enhancement to brief MI to improve behavior outcomes. It is introduced to patients by the study counselor at the end of the MI session.
Study NCT02294318 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Motivational Interviewing
Description: Motivational Interviewing is a client-centered counseling approach for eliciting behavior change.
Study NCT03143972 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Description: Single drug administration
Study NCT03143972 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Remifentanil
Description: Single drug administration
Study NCT02147496 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dietary Intervention
Study NCT02221271 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NPB-01
Study NCT02240745 — intervention group
Intervention type: OTHER
Intervention: Stress-echocardiography
Description: Stress-echocardiography (incl dobutamin and atropin)
Study NCT01975077 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: fruquintinib
Description: Fruquintinib is a capsule in the form of 1mg and 5mg, orally, daily
Study NCT02395653 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: fentanyl
Description: An opioid that has been administered parenterally as an anesthetic and analgesic for more than 20 years.
Study NCT02521623 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SurgiMend® Acellular Dermal Matrix
Description: See arm description.
Study NCT02521623 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Strattice™ Acellular Dermal Matrix
Description: See arm description.
Study NCT02858687 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nasopharyngeal swab
Study NCT02697630 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: 200 mg administered intravenously (IV) every third week until progression or unacceptable toxicity for a maximum of 24 months
Study NCT02697630 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Entinostat
Description: 5 mg by mouth (PO) once weekly until progression or unacceptable toxicity for a maximum of 24 months
Study NCT01540968 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Nutrition & physical exercise
Description: Patients will be randomly assigned to intensive individual nutritional counselling including oral nutritional supplements and a specifically designed exercise program combining strength and balance training.
Study NCT04213040 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Serum levels of Procalcitonin, C-reactive protein, lactate
Description: Serum PCT, CRP, and lactate values were collected postoperatively every day starting on postoperative 12 hours, postoperative days 1 through 5.~After the operation, all postoperative complications were recorded during the first seven days period.~The relations between diagnostic tests and postoperative complications are sought by the use of the statistical analysis methods.
Study NCT01225367 — intervention group
Intervention type: DEVICE
Intervention: ultrasound doppler monitoring
Description: Regular noninvasive chest echo monitoring
Study NCT02467829 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Increase in handle height
Description: Elbow flexion is measured with the child standing in their walker using an electronic goniometer. Approximately 10° of elbow flexion is current recommended practice. 30° and 50° are increased handle heights.
Study NCT03499080 — intervention group
Intervention type: BEHAVIORAL
Intervention: Medication free treatment
Description: Inpatient unit dedicated to medication free treatment. This is an inpatient treatment unit for voluntary, planned treatment. The unit is staffed for a patient group that can be managed within a regime of open doors, voluntary treatment and low supervision. This means that high suicidal risk, severe acting out, active drug abuse etc. is excluded. They have an 8 week treatment program including Illness managment an recovery (IMR), Feedback informed treatment (FIT) and Affect consciousness treatment (ABT).
Study NCT03499080 — intervention group
Intervention type: BEHAVIORAL
Intervention: Treatment as usual Myrvegen
Description: Inpatient unit on a different location from the others. Same Level of care. Different treatment program. Intermediate treatment duration (mainly 4-6 weeks).
Study NCT03499080 — intervention group
Intervention type: BEHAVIORAL
Intervention: Treatment as usual Åråsen
Description: Unit colocated with the medication free unit. Similar treatment program. Short treatment duration (average 3 weeks).
Study NCT02776956 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: atorvastatin group
Description: Patients in atorvastatin group will orally receive 20 mg of atorvastatin per night (Pfizer) for three days before the operation and three months after the operation
Study NCT02776956 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: non-atorvastatin group
Description: Patients in non-atorvastatin group will not receive atorvastatin before the operation and after the operation.
Study NCT02492087 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Topical tranexamic acid
Description: Topical tranexamic acid 2g diluted with normal saline 0.9% to a volume of 120mls solution (Concentration 16.7mg/ml)
Study NCT02759016 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 836826
Study NCT02759016 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ibrutinib
Description: Standard of Care
Study NCT02743195 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: OTHER
Intervention: Polyphenol/prebiotic blend
Study NCT02318134 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Fecal Microbiota Transplantation
Description: FMT via a nasoduodenal tube with fresh bacteria from healthy donor
Study NCT02318134 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: normal saline
Description: Normal saline via a nasoduodenal tube.
Study NCT00031694 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: paclitaxel
Description: Given IV
Study NCT00031694 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: bryostatin 1
Description: Given IV
Study NCT01925339 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Test (immediate restoration)
Description: Test (immediate restoration)
Study NCT01925339 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Control: delayed restoration
Description: Control: delayed restoration
Study NCT02619786 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Inhaled colistin
Description: 75 mg of colistin activity, inhaled per dose, every 12 hours
Study NCT03240978 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: exercise intervention
Description: A period of 12-week exercise intervention under the supervision of exercise specialists will be conducted.
Study NCT04537403 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Group 1-64CU-DOTA-ECL1i (radioactive imaging medicine)
Description: Patients in Group 1, normal volunteers and patients with carotid and femoral artery disease who will be having surgery, will have a 1 day imaging session lasting approximately 60 minutes with an injection of 64CU-DOTA-ECL1i to visualize the carotid and femoral arteries. Patients with carotid and femoral artery disease will have their plaque specimens collected for further sutdy
Study NCT04356118 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Recombinant Human Endostatin
Description: endostatin 7.5mg/㎡/d，Once a day for two weeks, take a week off,start the next cycle, up to four cycles .We advocate a highly individualized treatment plan according to each patients specific manifestations of the disease process.
Study NCT04356118 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: intrathcal methotrexate
Description: Intrathecal chemotherapy specified dose on specified days.
Study NCT04356118 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Targeted drugs for non-small cell lung cancer
Description: EGFR Mutation: Erlotinib，Afatinib，Osimertinib, et al. ALK ROS1 Mutation:Crizotinib,Ceritinib,Alectinib ,et al. BARF Mutation:Vemurafenib,et al. Other Mutation: other Targeted drugs .
Study NCT00841906 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Alice PDx with only written instructions
Description: Participants will be asked to follow the Alice PDx user instructions to apply basic leads and sensors and undergo a sleep study in their home. Participants will receive little or no instruction concerning the set up of the Alice PDx device. After the Alice PDx home study has proven successful, participants will return to the sleep center to undergo a second sleep study, the Lab Night, in which simultaneous monitoring with the Alice PDx and Alice 5 will be performed.
Study NCT00841906 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Alice PDx with written and verbal instructions
Description: Participants will be provided instruction by a trained sleep professional on the set up of the Alice PDx device. They will then be asked to follow the instructions for the Alice PDx device, if necessary, and undergo a sleep study in their home. After the Alice PDx home study has proven successful, participants will return to the sleep center to undergo a second sleep study, the Lab Night, in which simultaneous monitoring with the Alice PDx and Alice 5 will be performed.
Study NCT01193738 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: osteopathic compression of Pterygopalatine node
Description: osteopathic compression of Pterygopalatine node
Study NCT01193738 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: osteopathic compression of Pterygopalatine node
Description: osteopathic compression of Pterygopalatine node
Study NCT03826498 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CP CB-MNC injection
Description: CB-MNC injection from different donors. One dose consist 20-50 mil MNC/kg.The protocol include 3 injection at monthly intervals.
Study NCT03826498 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard therapy
Description: The standard therapy can include drugs, special psychology training etc.
Study NCT03826498 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Standard therapy
Description: The standard therapy can include drugs, special psychology training etc.
Study NCT00683982 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nitazoxanide
Description: Nitazoxanide 15mg/Kg/day twice day for 3 days
Study NCT00683982 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Probiotic mix preparation
Description: Probiotic preparation 1 gram twice a day for 5 days
Study NCT00683982 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Oral hydration solutions
Description: Oral hydration solutions as needed
Study NCT02429141 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: US-guided periarterial techique
Description: The needle will be inserted in the axillary fossa in-plane (cranial to caudal) close to the intersection of the pectoralis and biceps muscles. Two separate injections of local anesthetic will be made deep and superficial to the axillary artery
Study NCT02429141 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: US-guided multi-injection technique
Description: The median, ulnar and radial nerves will be identified by ultrasound. Local anesthetic will be injected adjacent to each nerve
Study NCT00212576 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Video Interaction Project
Description: While waiting to see the primary care provider for well child care, the family meets with a child development specialist, who videotapes the parent and infant interacting together. The videotape is then rewound and watched together by the parent and child development specialist. This leads to a discussion about child development, infant cues and parenting, with the child development specialist building on observed strengths in the interaction. In addition, families are provided with parenting pamphlets developed for the project, and with inexpensive developmentally stimulating toys.
Study NCT00212576 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Building Blocks Project
Description: This project employs a public health approach to facilitate parental engagement in child development. Families are sent monthly newsletters that focus on child development, infant cues and parenting; included with each newsletter is an inexpensive, developmentally stimulating toy. In addition, families periodically receive Ages and Stages Questionnaires, which they complete and mail back to the program. Based on the questionnaires, the program determines whether the infant has screened positive for possible developmental delay and provides this information to both the family and the primary care provider.
Study NCT02505490 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Television
Description: The purpose is to determine whether television impacts liking of food.
Study NCT02505490 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: No Television
Description: The purpose is to determine whether the lack of television impacts liking of food.
Study NCT04481178 — intervention group
Intervention type: OTHER
Intervention: Laser (QS, Picosecond laser)
Description: QS-Nd Yag Laser, Picosecond laser
Study NCT00100802 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies
Study NCT00100802 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lomustine
Description: Given PO
Study NCT00100802 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiation Therapy
Description: Undergo radiation therapy
Study NCT00100802 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Temozolomide
Description: Given PO
Study NCT03384238 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Panitumumab-IRDye800
Description: Given IV
Study NCT04537403 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Group 2 64CU-DOTA-ECL1i (radioactive imaging medicine)
Description: Patients in Group 2, who are patients with carotid and femoral artery disease who will not be having surgery will have two imaging sessions 7-14 days apart
Study NCT02444858 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: UCMSC group
Description: Human umbilical cord MSCs are transplanted by intravenous injection(5×10\^5/kg) ，once a day,a total of three times.
Study NCT02444858 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Control group(Normal saline)
Description: Normal saline in same volume as MSCs are transplanted to patients.
Study NCT05799742 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bilateral hernioplasty
Study NCT02492087 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Normal saline 0.9%
Description: Sterile Normal saline 0.9% 120mls solution
Study NCT04031053 — intervention group
Intervention type: OTHER
Intervention: Pharmacokinetic study
Description: The blood will be collected at pre-dose and at 1, 3, 4, 5, 6, 8 and 12-hour post dose
Study NCT02586077 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Exparel
Study NCT03807076 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: GIP-A
Description: GIP-A
Study NCT03807076 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT03853512 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BAY207543 (Bepanthol, Bepantol® Derma Spray)
Description: Product is applied to one side of the inguinal region.
Study NCT03853512 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: BAY207543 (Bepanthol, Bepantol® Derma Spray)
Description: Product is applied to one side of the inguinal region.
Study NCT03853512 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Semisolid vaseline
Description: Product is applied to the other side of the inguinal region.
Study NCT03853512 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Semisolid vaseline
Description: Product is applied to the other side of the inguinal region.
Study NCT04077229 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intervention arm: Text Message Intervention
Description: Participants will receive a combination of messages promoting both psychological well-being and education /support around health behavior adherence, such as physical activity or diet. In the first part of the study, participants will receive 28 fixed text messages that alternate between physical activity and PP (Positive Psychology) messages. In the second part of the study, participants will first receive a set of 14 pre-selected daily messages that contain a broad range of attributes to allow sufficient participant feedback to clearly identify preferences. After the first 14 messages, new messages will be selected based on the prior preferences of participants.
Study NCT01059396 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: propranolol
Description: GPVH ≥ 10 mmHg - responders: propranolol.
Study NCT01059396 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: carvedilol
Description: GPVH ≥ 10 mmHg nonresponders: carvedilol.
Study NCT01059396 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: placebo propranolol / carvedilol